Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Apr 24, 2024
Product Development
Clinical report: Sanofi data advances pair of autoimmune disease mechanisms
Plus: Neurocrine hits in Phase II depression study and updates from Cerevel, Sage, Ventus, Lilly and AbbVie
Read More
BioCentury
|
Aug 18, 2018
Regulation
Pediatric push
Why companies should invest in data, alliances to support pediatric extrapolation
Read More
BioCentury
|
May 5, 2018
Product Development
Rebuilding Biogen’s brain
What Biogen is building in neurology
Read More
BioCentury
|
May 4, 2018
Company News
Accelerator launches Proniras to develop anticonvulsant
Read More
BioCentury
|
Apr 24, 2018
Company News
Biogen looks to ex-U.S. markets for growth
Read More
BioCentury
|
Mar 16, 2018
Company News
Biogen scoops up neuropsychiatry candidate from Pfizer
Read More
BioCentury
|
Mar 12, 2018
Company News
Biogen scoops up neuropsychiatry candidate from Pfizer
Read More
BioCentury
|
Aug 10, 2017
Clinical News
FDA approves Eisai's seizure drug Fycompa for monotherapy use
Read More
BioCentury
|
Dec 15, 2016
Translation in Brief
Fore score
How Cerecor's forebrain-specific GRIA antagonist sidelines GRIA's side effects
Read More
BioCentury
|
Nov 2, 2016
Clinical News
Fycompa: Ph III started
Read More
Items per page:
10
1 - 10 of 68
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help